Literature DB >> 11597593

GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons.

K Nakajima1, H Hida, Y Shimano, I Fujimoto, T Hashitani, M Kumazaki, T Sakurai, H Nishino.   

Abstract

Extracts from dopamine (DA)-depleted striatal tissue (lesion extract) and from intact striatal tissue (intact extract) were prepared, and trophic activities in these extracts were evaluated using survival and neurite extension of DAergic neurons as indices. Levels of brain-derived neurotrophic factor (BDNF), basic fibroblast growth factor (bFGF), glial cell-line derived neurotrophic factor (GDNF) and neurotrophin-3 (NT-3) in extracts were measured using enzyme-linked immunosorbent assay (ELISA). The lesion extract exhibited a stronger trophic activity on survival and neurite extension of DAergic neurons than intact extract. In lesion extract, bFGF was slightly and GDNF was significantly increased, while BDNF and NT-3 were the same level in each extract. The peak increase of bFGF and GDNF was during 2 to 3 weeks after DA depletion. Trophic activity of extract was strongly attenuated after immunoprecipitation of GDNF and partly attenuated after immunoprecipitation of bFGF. In parallel immunohistological study, no significant variations were found for striatal microtubule-associated protein-2 (MAP-2)- nor OX-41-immunoreactive cells, while the number of strongly labeled glial fibrillary acidic protein (GFAP)-immunoreactive cells were increased in DA-depleted striatum, suggesting reactive gliosis. Data suggest that bFGF is a minor, while GDNF is a major component of trophic activity for DAergic neurons in DA-depleted striatum, and increased bFGF and GDNF levels may be mediated partly by reactive gliosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597593     DOI: 10.1016/s0006-8993(01)02866-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.

Authors:  Nicolas Giguère; Consiglia Pacelli; Caroline Saumure; Marie-Josée Bourque; Diana Matheoud; Daniel Levesque; Ruth S Slack; David S Park; Louis-Éric Trudeau
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

2.  Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease.

Authors:  B A Morrow; R H Roth; D E Redmond; J D Elsworth
Journal:  Neuroscience       Date:  2011-06-01       Impact factor: 3.590

3.  Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures.

Authors:  Sara af Bjerkén; Heather A Boger; Matthew Nelson; Barry J Hoffer; Ann-Charlotte Granholm; Ingrid Strömberg
Journal:  Brain Res       Date:  2006-12-19       Impact factor: 3.252

4.  Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice.

Authors:  Ofelia M Littrell; Francois Pomerleau; Peter Huettl; Stewart Surgener; Jacqueline F McGinty; Lawrence D Middaugh; Ann-Charlotte Granholm; Greg A Gerhardt; Heather A Boger
Journal:  Neurobiol Aging       Date:  2010-12-08       Impact factor: 4.673

5.  Neural stem-like cells derived from human amnion tissue are effective in treating traumatic brain injury in rat.

Authors:  Zhong-Jie Yan; Peng Zhang; Yu-Qin Hu; Hong-Tian Zhang; Sun-Quan Hong; Hong-Long Zhou; Mao-Ying Zhang; Ru-Xiang Xu
Journal:  Neurochem Res       Date:  2013-03-10       Impact factor: 3.996

6.  Strain difference in the up-regulation of FGF-2 protein following a neurotoxic lesion of the nigrostriatal pathway.

Authors:  David M Yurek; Anita M Fletcher; Laura E Peters; Wayne A Cass
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

Review 7.  Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease.

Authors:  Hironori Yokoyama; Hayato Kuroiwa; Ryohei Yano; Tsutomu Araki
Journal:  Neurol Sci       Date:  2008-10-21       Impact factor: 3.307

8.  Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease.

Authors:  Merav Bahat-Stroomza; Yael Barhum; Yossef S Levy; Olga Karpov; Shlomo Bulvik; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2009-01-06       Impact factor: 3.444

9.  Astrocyte-like cells derived from human oral mucosa stem cells provide neuroprotection in vitro and in vivo.

Authors:  Javier Ganz; Ina Arie; Tali Ben-Zur; Michal Dadon-Nachum; Sammy Pour; Shareef Araidy; Sandu Pitaru; Daniel Offen
Journal:  Stem Cells Transl Med       Date:  2014-01-29       Impact factor: 6.940

10.  Characterization of the stability and bio-functionality of tethered proteins on bioengineered scaffolds: implications for stem cell biology and tissue repair.

Authors:  Ting-Yi Wang; Kiara A F Bruggeman; Rebecca K Sheean; Bradley J Turner; David R Nisbet; Clare L Parish
Journal:  J Biol Chem       Date:  2014-04-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.